公开(公告)号：FI973282A0

公开(公告)日：1997-08-08

申请号：FI973282

申请日：1997-08-08

Applicant: BASF AG

Inventor： SEITZ WERNER ,  MACK HELMUT ,  ZIERKE THOMAS ,  BOEHM HANS-JOACHIM ,  HOEFFKEN HANS WOLFGANG ,  KOSER STEFAN ,  PFEIFFER THOMAS ,  HORNBERGER WILFRIED

IPC: A61K38/55 ,  A61K38/00 ,  A61P7/02 ,  C07K5/06 ,  C07K5/065 ,  C07K5/072 ,  C07K5/087 ,  C07K

Abstract: PCT No. PCT/EP96/00472 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Feb. 6, 1996 PCT Pub. No. WO96/24609 PCT Pub. Date Aug. 15, 1996Thrombin inhibitors of the formula where R1, A, B and D have the meaning indicated in the description, and intermediates for the preparation thereof are described. The compounds I are suitable for controlling diseases.

公开(公告)号：MX9606521A

公开(公告)日：1997-05-31

申请号：MX9606521

申请日：1995-06-06

Applicant: BASF AG

Inventor： BOHM HANS-JOACHIM ,  KOSER STEFAN ,  MACK HELMUT ,  PFEIFFER THOMAS ,  SEITZ WERNER ,  WOLFGANG HANS ,  HORNBERGER WILFRIED

IPC: A61K31/40 ,  A61K38/00 ,  A61K38/05 ,  A61K38/55 ,  A61K47/48 ,  A61P7/02 ,  C07C279/00 ,  C07D205/04 ,  C07D207/06 ,  C07D207/16 ,  C07D207/48 ,  C07D211/60 ,  C07K5/06 ,  C07K5/065 ,  C07K5/072 ,  C07K5/078 ,  C07K05/06

Abstract: Se describen compuestos de la formula (Ver Formula) y las sales de los mismos con ácidos fisiologicamente tolerados y los estereoisomeros de los mismos, en donde los sustituyentes tienen los significados indicados en la descripcion. Se presentan también productos intermedios para su preparacion. Los compuestos son adecuados para controlar enfermedades.

公开(公告)号：CA2211109A1

公开(公告)日：1996-08-22

申请号：CA2211109

申请日：1996-02-12

Applicant: BASF AG

Inventor： PFEIFFER THOMAS ,  ZIERKE THOMAS ,  B HM HANS-JOACHIM ,  SEITZ WERNER ,  KOSER STEFAN ,  HORNBERGER WILFRIED ,  H FFKEN HANS WOLFGANG ,  MACK HELMUT

IPC: A61K31/00 ,  A61K38/55 ,  A61P7/02 ,  C07D205/04 ,  C07D207/16 ,  C07D213/53 ,  C07D213/63 ,  C07D213/72 ,  C07D213/78 ,  C07D213/79 ,  C07D239/28 ,  C07D241/14 ,  C07D241/24 ,  C07D401/12 ,  C07K5/06 ,  C07K5/062 ,  C07K5/078 ,  C07J43/00 ,  A61K38/05 ,  C07F7/10 ,  C07D403/12 ,  C07D413/12 ,  C07D417/12 ,  C07D405/14 ,  C07D217/26 ,  A61K31/40 ,  A61K31/435 ,  C07F9/547 ,  C07C255/58 ,  A61K31/58 ,  C07D211/60 ,  A61K31/675 ,  A61K31/695 ,  C07D213/81 ,  C07D213/84

Abstract: The description relates to compounds of formula (I) in which A, B, D, R1 and R2 have the meanings given in the specification. The compounds are suitable for the treatment of diseases. The novel compounds are produced via compounds of the formula H2N-CH2-G-M in which G and M have the meanings given in claim 4.

公开(公告)号：MX9203910A

公开(公告)日：1993-01-01

申请号：MX9203910

申请日：1992-07-02

Applicant: BASF AG

Inventor： MACK HELMUT ,  PFEIFFER THOMAS ,  HOEFFKERN HANS WOLFGANG ,  BOEHM HANS-JOACHIM ,  HORNBERGER WILFRIED

IPC: A61K38/00 ,  A61K38/55 ,  A61K38/05 ,  A61P7/02 ,  C07K1/113 ,  C07K5/06 ,  C07K5/062 ,  C07K5/065 ,  C07K5/078 ,  C07C257/18

Abstract: PCT No. PCT/EP92/01411 Sec. 371 Date Dec. 28, 1993 Sec. 102(e) Date Dec. 28, 1993 PCT Filed Jun. 23, 1992 PCT Pub. No. WO93/01208 PCT Pub. Date Jan. 21, 1993.2-Substituted 3-(4-amidinophenyl)propionic acid derivatives of the formula in which A, Ar and B have the meanings stated in the description, and the preparation thereof are described. The compounds are suitable for controlling diseases.

公开(公告)号：HRP960075B1

公开(公告)日：2004-10-31

申请号：HRP960075

申请日：1996-02-15

Applicant: BASF AG

Inventor： BOEHM HANS-JOACHIM ,  HOEFFKEN HANS WOLFGANG ,  HORNBERGER WILFRIED ,  KOSER STEFAN ,  MACK HELMUT ,  PFEIFFER THOMAS ,  SEITZ WERNER ,  ZIERKE THOMAS

IPC: A61K31/00 ,  A61K38/55 ,  A61P7/02 ,  C07D205/04 ,  C07D207/16 ,  C07D213/53 ,  C07D213/63 ,  C07D213/72 ,  C07D213/78 ,  C07D213/79 ,  C07D239/28 ,  C07D241/14 ,  C07D241/24 ,  C07D401/12 ,  C07K5/06 ,  C07K5/062 ,  C07K5/078 ,  A61K31/40 ,  A61K31/445 ,  A61K31/495

Abstract: The invention relates to a compound of the formula I: or a salt thereof with a physiologically tolerated acid, or stereoisomers thereof, wherein R 1 , R 2 , A, B, C and D have the meanings described in the specification.

公开(公告)号：DE59510645D1

公开(公告)日：2003-05-22

申请号：DE59510645

申请日：1995-06-06

Applicant: BASF AG

Inventor： BOEHM HANS-JOACHIM ,  KOSER STEFAN ,  MACK HELMUT ,  PFEIFFER THOMAS ,  SEITZ WERNER ,  HOEFFKEN WOLFGANG ,  HORNBERGER WILFRIED

IPC: A61K31/40 ,  A61K38/00 ,  A61K38/05 ,  A61K38/55 ,  A61K47/48 ,  A61P7/02 ,  C07C279/00 ,  C07D205/04 ,  C07D207/06 ,  C07D207/16 ,  C07D207/48 ,  C07D211/60 ,  C07K5/06 ,  C07K5/065 ,  C07K5/072 ,  C07K5/078

Abstract: Compounds of the formula and the salts thereof with physiologically tolerated acids and the stereoisomers thereof, in which the substituents have the meanings stated in the description, are described. Also disclosed are intermediates for their preparation. The compounds are suitable for controlling diseases.

公开(公告)号：EA002767B1

公开(公告)日：2002-08-29

申请号：EA199700155

申请日：1996-02-06

Applicant: BASF AG

Inventor： SEITZ WERNER ,  MACK HELMUT ,  ZIERKE THOMAS ,  BOHM HANS-JOACHIM ,  HOFFKEN HANS WOLFGANG ,  KOSER STEFAN ,  PFEIFFER THOMAS ,  HORNBERGER WILFRIED

IPC: A61K38/55 ,  A61K38/00 ,  A61P7/02 ,  C07K5/06 ,  C07K5/065 ,  C07K5/072 ,  C07K5/087

Abstract: Описываютсяингибиторытромбинаформулы (I)где R, А, Ви D имеютуказанныев п.1 формулыизобретениязначения,иихстереоизомерыи ихсолис физиологическипереносимымикислотами, вкоторыхамидиноваяфункцияможетиметьсяв моно- илибис-защищеннойформе. Данныесоединениямогутприменятьсядлялеченияи профилактикиразличногородатромбинзависящихсобытий. Дополнительнымиобъектамиизобретенияявляютсясоединенияформул (VII) и (VIII)где R, А, Ви D имеютуказанноев п.1 формулыизобретениязначение, ив формуле (VII) амидиноваяфункцияможетиметьсяв моно- илибис-защищеннойформе,которыепредставляютсобойпромежуточныепродуктыдляполучениясоединенийформулы (I). Крометого, онипредставляютсобойценныевеществадлясинтезаингибиторовсеринпротеазы. Дальнейшимобъектомизобретенияявляетсяструктурныйфрагментформулы (IX)которыйпредставляетсобойценныйкомпонентингибиторовсеринпротеазы, ив частностиингибиторовтромбина.

公开(公告)号：BG105978A

公开(公告)日：2002-07-31

申请号：BG10597801

申请日：2001-10-04

Applicant: BASF AG

Inventor： HILLEN HEINZ ,  SCHMIDT MARTIN ,  MACK HELMUT ,  SEITZ WERNER ,  HAUPT ANDREAS ,  ZEICHEL JOHANN-CHRISTIA ,  KLING ANDREAS

IPC: C12N9/99 ,  A61K38/00 ,  A61K38/55 ,  A61P1/04 ,  A61P1/18 ,  A61P5/14 ,  A61P7/02 ,  A61P9/00 ,  A61P9/10 ,  A61P11/00 ,  A61P11/06 ,  A61P13/12 ,  A61P15/00 ,  A61P17/02 ,  A61P19/02 ,  A61P21/04 ,  A61P25/00 ,  A61P25/28 ,  A61P29/00 ,  A61P37/02 ,  C07B43/00 ,  C07D401/12 ,  C07D409/12 ,  C07K5/06 ,  C07K5/062 ,  C07K5/065 ,  C07K5/068 ,  C07K5/072 ,  C07K5/078

Abstract: The invention relates to peptidic substances, to the production of said substances and to their use as complement inhibitors. In particular, the invention relates to substances with a guanadine or amidine radical as the terminal group, especially inhibitors of the complement proteases C1s and C1r. 8 claims

公开(公告)号：BR0009678A

公开(公告)日：2002-01-22

申请号：BR0009678

申请日：2000-03-28

Applicant: BASF AG

Inventor： HILLEN HEINZ ,  SCHMIDT MARTIN ,  MACK HELMUT ,  SEITZ WERNER ,  HAUPT ANDREAS ,  ZECHEL JOHANN-CHRISTIAN ,  KLING ANDREAS

IPC: C12N9/99 ,  A61K38/00 ,  A61K38/55 ,  A61P1/04 ,  A61P1/18 ,  A61P5/14 ,  A61P7/02 ,  A61P9/00 ,  A61P9/10 ,  A61P11/00 ,  A61P11/06 ,  A61P13/12 ,  A61P15/00 ,  A61P17/02 ,  A61P19/02 ,  A61P21/04 ,  A61P25/00 ,  A61P25/28 ,  A61P29/00 ,  A61P37/02 ,  C07B43/00 ,  C07D401/12 ,  C07D409/12 ,  C07K5/06 ,  C07K5/062 ,  C07K5/065 ,  C07K5/068 ,  C07K5/072 ,  C07K5/078

Abstract: Peptide substances, their preparation and their use as complement inhibitors are described. These are in particular substances having a guanidine or amidine radical as a terminal group. In particular, inhibitors of the complement proteases C1s and C1r are described.

公开(公告)号：NO20014876L

公开(公告)日：2001-12-04

申请号：NO20014876

申请日：2001-10-08

Applicant: BASF AG

Inventor： HILLEN HEINZ ,  SCHMIDT MARTIN ,  MACK HELMUT ,  SEITZ WERNER ,  HAUPT ANDREAS ,  ZECHEL JOHANN-CHRISTIAN ,  KLING ANDREAS

IPC: A61K38/00 ,  A61K38/55 ,  C12N9/99 ,  A61P1/04 ,  A61P1/18 ,  A61P5/14 ,  A61P7/02 ,  A61P9/00 ,  A61P9/10 ,  A61P11/00 ,  A61P11/06 ,  A61P13/12 ,  A61P15/00 ,  A61P17/02 ,  A61P19/02 ,  A61P21/04 ,  A61P25/00 ,  A61P25/28 ,  A61P29/00 ,  A61P37/02 ,  C07B43/00 ,  C07D401/12 ,  C07D409/12 ,  C07K5/06 ,  C07K5/062 ,  C07K5/065 ,  C07K5/068 ,  C07K5/072 ,  C07K5/078 ,  A61K38/05

Abstract: Peptide substances, their preparation and their use as complement inhibitors are described. These are in particular substances having a guanidine or amidine radical as a terminal group. In particular, inhibitors of the complement proteases C1s and C1r are described.